The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of restoration of microRNA-18a on improvement of imatinib therapy on secondary imatinib-resistance metastatic melanoma.
Jun Guo
No relevant relationships to disclose
Yan Kong
No relevant relationships to disclose
Long Liang
No relevant relationships to disclose
Yiqian Li
No relevant relationships to disclose
Xiao Wei Xu
No relevant relationships to disclose
Lu Si
No relevant relationships to disclose
Zhihong Chi
No relevant relationships to disclose
Chuan Liang Cui
No relevant relationships to disclose
Xi Nan Sheng
No relevant relationships to disclose
Jie Dai
No relevant relationships to disclose